PanGen Biotech Inc. (KOSDAQ:222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
+180.00 (3.06%)
At close: Dec 5, 2025

PanGen Biotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
3,1861,43045.4838.288,9018,139
Upgrade
Short-Term Investments
10,04710,002149.24215,19910,550
Upgrade
Cash & Short-Term Investments
13,23311,432194.64840.2824,10018,689
Upgrade
Cash Growth
121.05%5773.48%-76.84%-96.51%28.95%-23.29%
Upgrade
Accounts Receivable
2,1112,9592,208689.811,089535.34
Upgrade
Other Receivables
20051.88.54221.29241.03176.87
Upgrade
Receivables
2,3113,2612,330974.11,393775.21
Upgrade
Inventory
6,8746,0016,9256,6304,3733,764
Upgrade
Prepaid Expenses
35.3753.9658.9171.4121.3915.49
Upgrade
Other Current Assets
883.9620.35333.6260.911,267847.87
Upgrade
Total Current Assets
23,33820,7689,8438,57631,15424,092
Upgrade
Property, Plant & Equipment
5,8115,8056,2406,6086,7486,029
Upgrade
Long-Term Investments
0000-00
Upgrade
Other Intangible Assets
951.86785.13879.93269.63313.41271.58
Upgrade
Long-Term Deferred Charges
2,1302,6223,2783,9334,5895,244
Upgrade
Other Long-Term Assets
533.58564.14501.51,287473.47673.02
Upgrade
Total Assets
32,76530,54520,74120,67443,27736,309
Upgrade
Accounts Payable
264.32423.33298.82255.48381.91296.57
Upgrade
Accrued Expenses
179.79-----
Upgrade
Short-Term Debt
923.03816.32,014-18,69218,399
Upgrade
Current Portion of Leases
0.871.841.691.561.43-
Upgrade
Other Current Liabilities
1,3711,6573,396872.49811.141,395
Upgrade
Total Current Liabilities
2,7392,8995,7111,13019,88620,091
Upgrade
Long-Term Leases
-0.392.243.935.49-
Upgrade
Pension & Post-Retirement Benefits
-2,7072,4322,1142,1711,930
Upgrade
Other Long-Term Liabilities
-3030206.41116.2277.31
Upgrade
Total Liabilities
2,7395,6368,1753,45422,17922,098
Upgrade
Common Stock
6,7476,4495,3395,3395,3364,821
Upgrade
Additional Paid-In Capital
10,17667,71257,40257,40257,37147,840
Upgrade
Retained Earnings
11,799-49,953-50,876-46,210-42,062-38,680
Upgrade
Comprehensive Income & Other
1,303700.82700.82688.64452.86229.89
Upgrade
Total Common Equity
30,02624,90912,56617,21921,09814,211
Upgrade
Shareholders' Equity
30,02624,90912,56617,21921,09814,211
Upgrade
Total Liabilities & Equity
32,76530,54520,74120,67443,27736,309
Upgrade
Total Debt
923.89818.542,0185.4918,69918,399
Upgrade
Net Cash (Debt)
12,31010,614-1,823834.795,402290.4
Upgrade
Net Cash Growth
232.19%---84.55%1760.05%-95.84%
Upgrade
Net Cash Per Share
950.70927.83-170.6078.21528.6930.13
Upgrade
Filing Date Shares Outstanding
13.6412.910.6810.6810.679.64
Upgrade
Total Common Shares Outstanding
13.6412.910.6810.6810.679.64
Upgrade
Working Capital
20,60017,8694,1327,44711,2674,001
Upgrade
Book Value Per Share
2201.421931.181176.851612.671976.951473.91
Upgrade
Tangible Book Value
29,07424,12411,68616,95020,78413,940
Upgrade
Tangible Book Value Per Share
2131.631870.311094.441587.421947.581445.75
Upgrade
Land
1,1741,1741,1741,1741,1741,004
Upgrade
Buildings
3,9093,9093,9093,9093,9093,456
Upgrade
Machinery
12,05011,76611,54511,43410,3819,811
Upgrade
Construction In Progress
112.7-125.36-332.661.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.